摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1,12-dodecano-bis(L-Phe) | 182684-42-0

中文名称
——
中文别名
——
英文名称
1,12-dodecano-bis(L-Phe)
英文别名
(2S)-2-amino-N-[12-[[(2S)-2-amino-3-phenylpropanoyl]amino]dodecyl]-3-phenylpropanamide
1,12-dodecano-bis(L-Phe)化学式
CAS
182684-42-0
化学式
C30H46N4O2
mdl
——
分子量
494.721
InChiKey
SDTMQKDEKXSQIW-NSOVKSMOSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.7
  • 重原子数:
    36
  • 可旋转键数:
    19
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.53
  • 拓扑面积:
    110
  • 氢给体数:
    4
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    与-Phe-Phe-和-Phe-Phe-X序列缀合的新型迷你平行双链肽的合成,构象和化学性质。
    摘要:
    为了研究与阿尔茨海默氏病相关的β-淀粉样肽中所含的-Phe-Phe-Val-或-Phe-Phe-序列的化学构象和功能,这是一系列与两个肽残基缀合在一起的微型平行双链肽设计并准备了垫片。通过圆二色性(CD)光谱和NMR二维(2D)核Overhauser增强和交换光谱(NOESY)测量来阐明化合物的结构。1,2-乙醇双(L-Phe-L-Phe-L-Leu),1,12-十二烷双(L-Phe-L-Phe-L-Leu),1,12-十二烷的结构-bis(L-Phe-L-Phe-L-Val)和1,12-十二烷(D-Phe-D-Phe-D-Leu)与L-Leu和L-Val残基缀合显示β角形核。二面角(θ= +75度,ω= +180度,phi = +90度,phi = -87度,从实验耦合常数(J)数据等获得的psi = +180度)支持1,12-十二烷双(L-Phe-L-Phe)采用β-转角模拟成核。1,
    DOI:
    10.1248/cpb.48.920
  • 作为产物:
    描述:
    1,12-二氨基十二烷 在 palladium on activated charcoal 氢气N,N'-羰基二咪唑 作用下, 以 甲醇氯仿N,N-二甲基甲酰胺 为溶剂, 反应 1.5h, 生成 1,12-dodecano-bis(L-Phe)
    参考文献:
    名称:
    与-Phe-Phe-和-Phe-Phe-X序列缀合的新型迷你平行双链肽的合成,构象和化学性质。
    摘要:
    为了研究与阿尔茨海默氏病相关的β-淀粉样肽中所含的-Phe-Phe-Val-或-Phe-Phe-序列的化学构象和功能,这是一系列与两个肽残基缀合在一起的微型平行双链肽设计并准备了垫片。通过圆二色性(CD)光谱和NMR二维(2D)核Overhauser增强和交换光谱(NOESY)测量来阐明化合物的结构。1,2-乙醇双(L-Phe-L-Phe-L-Leu),1,12-十二烷双(L-Phe-L-Phe-L-Leu),1,12-十二烷的结构-bis(L-Phe-L-Phe-L-Val)和1,12-十二烷(D-Phe-D-Phe-D-Leu)与L-Leu和L-Val残基缀合显示β角形核。二面角(θ= +75度,ω= +180度,phi = +90度,phi = -87度,从实验耦合常数(J)数据等获得的psi = +180度)支持1,12-十二烷双(L-Phe-L-Phe)采用β-转角模拟成核。1,
    DOI:
    10.1248/cpb.48.920
点击查看最新优质反应信息

文献信息

  • Refining hydrogelator design: soft materials with improved gelation ability, biocompatibility and matrix for in situ synthesis of specific shaped GNP
    作者:Dibyendu Das、Subhabrata Maiti、Sayanti Brahmachari、Prasanta Kumar Das
    DOI:10.1039/c1sm05608e
    日期:——
    Despite the continuous surge in the development of new supramolecular gels, the prediction of a gelator's structure still remains elusive. It is also imperative to consolidate the existing inventory of gelators and devise ways to make the gels functional. In the present work, L-phenylalanine based poor (C-16) or non-gelating (C-12 tail) amphiphiles were converted to excellent gelators with the simple incorporation of N-terminal protected amino acid/dipeptide at the end of the alkyl tail. More than 6-fold enhancement in gelation efficiency was observed for amino acid/dipeptides incorporated at the tail of amphiphile in comparison to the corresponding unmodified alkyl tail. Interestingly, amphiphile with the tertiary butyloxycarbonyl (Boc) protected amino acid at the tail had better gelation ability than the amphiphile with the aromatic Fmoc (N-fluorenyl-9-methoxycarbonyl) protecting group. Spectroscopic investigations (XRD and FTIR) revealed that the modification at the tail compels the amphiphiles to take a different course of self-assembly than that adopted by their predecessors (alkyl tailed gelator, C-16). For example, in the case of the amphiphile having a dipeptide at the tail, formation of β-sheet structure through anti-parallel arrangement between the molecules results in notable improvement in its gelation ability. Most importantly, these tail modified amphiphiles were capable of in situ synthesis of gold nanoparticles (GNPs) of specific shape without the help of any external reducing agents in the newly developed soft materials. The biocompatibility of hydrogels is also crucial for their prolific biomedicinal functions. MTT assay showed dramatic improvement in the biocompatibility of the tail modified hydrogelators towards mammalian cells in comparison to the amphiphiles having no amino acid at the tail.
    尽管新型超分子凝胶的发展持续激增,但凝胶剂结构的预测仍然难以捉摸。同样迫切的是整合现有凝胶剂清单,并设计方法使凝胶具有功能性。在本研究中,基于L-苯丙氨酸的不良(C-16)或非凝胶化(C-12尾部)的两性分子,通过简单地在烷基尾部末端引入N端保护的氨基酸/二肽,转化为优秀的凝胶剂。与未修饰的相应烷基尾部相比,在两性分子尾部引入氨基酸/二肽后,凝胶化效率提高了6倍以上。有趣的是,尾部带有叔丁氧羰基(Boc)保护氨基酸的两性分子比尾部带有芳香性Fmoc(N-基-9-甲氧羰基)保护基的两性分子具有更好的凝胶化能力。光谱学研究(XRD和FTIR)揭示,尾部的修饰迫使两性分子采取与前身(烷基尾部凝胶剂,C-16)不同的自组装途径。例如,在尾部具有二肽的两性分子中,通过分子间的反平行排列形成β-折叠结构,显著改善了其凝胶化能力。最重要的是,这些尾部修饰的两性分子能够在新型软材料中,无需任何外部还原剂的帮助,实现特定形状纳米颗粒(GNPs)的原位合成。凝胶的生物相容性对其丰富的生物医学功能也至关重要。MTT assay显示,与尾部没有氨基酸的两性分子相比,尾部修饰的凝胶剂对哺乳动物细胞的生物相容性有了显著提高。
  • Exceptional adhesive and gelling properties of fibrous nanoscopic tapes of self-assembled bipolar urethane amides of L-phenylalanine
    作者:Santanu Bhattacharya、S. N. Ghanashyam Acharya、A. R. Raju
    DOI:10.1039/cc9960002101
    日期:——
    Seven L-phenylalanine based alkyl (monopolar) and alkanediyl (bipolar) derivatives are synthesized; while the bipolar urethane amides form gels and show strong adhesive properties, the monopolar analogues form fibrous nanoscopic cloth-like tapes.
    合成了七种基于L-苯丙氨酸的烷基(单极性)和烷二基(双极性)衍生物;而双极性氨基甲酸酯酰胺形成凝胶并显示出强烈的粘附性,单极性类似物则形成纤维状的纳米级布状带。
  • Diastereomer-Specific Effects of Double-Stranded Peptides Conjugated with -L-Tyr-L-Phe- or -L-Tyr-D-Phe- Residues on Tyrosine Phosphorylation and Inhibition of srctsNRK, A431, MCF-7, and DU145 Cell Growth
    作者:Shigeki Kobayashi、Nahomi Atuchi、Hidetaka Wakamatsu、Mayuko Hattori、Ayumi Kawada、Kouji Asano
    DOI:10.1248/cpb.55.1585
    日期:——
    The interaction between growth inhibition and chirality, especially of diastereomers, has an important modifying effect on cancer cell proliferation. Previously, we have reported on the design, synthesis, and chemical properties of a series of novel, double-stranded peptides, (y-AA–x-AA)2-(CH2)12, with –y-AA–x-AA– and –z-AA–y-AA–x-AA– sequences conjugated to the spacer. Here, we extend those results by showing that (D-, L-) and (L-, D-) diastereomers are more potent inhibitors of tyrosine phosphorylation than (L-, L-). Although the replacement of the L-Phe–L-Phe sequence with L-Tyr–L-Phe produces a less active inhibitor, the double-stranded peptide conjugated with L-Tyr–D-Phe is more active than that conjugated with L-Tyr–L-Phe. In addition, we show that SDS-PAGE gel profiles of tyrosine phosphorylation following treatment with bis(y-Tyr–x-Phe)-N,N-dodecane-1,12-diamine appear very similar to profiles of tyrosine phosphorylation following treatment with an analog of the tyrosine kinase inhibitor, erbstatin. Moreover, the level of autophosphorylation of the epidermal growth factor receptor kinase domain (EGFRKD) treated with bis(L-Tyr–D-Phe)-N,N-dodecane-1,12-diamine was lower than that seen following treatment with bis(L-Phe–D-Phe)-N,N-dodecane-1,12-diamine. These data provide new insights for the control of cancer cell proliferation through drug designs which replace the less active –L-Phe–L-Phe– (and –D-Phe–L-Phe–) with the more active –L-Tyr–L-Phe- (and –L-Tyr–D-Phe–) sequence.
    生长抑制与手性之间的相互作用,特别是对映异构体的相互作用,对癌细胞增殖具有重要的修饰效应。此前,我们报告了一系列新颖的双链肽(y-AA–x-AA)₂-(CH₂)₁₂的设计、合成和化学性质,其中包含与间隔连接的–y-AA–x-AA–和–z-AA–y-AA–x-AA–序列。在这里,我们扩展了这些结果,表明(D-,L-)和(L-,D-)对映异构体在酪氨酸磷酸化的抑制效果上比(L-,L-)更强。尽管用L-Tyr–L-Phe序列替换L-Phe–L-Phe序列会产生活性较低的抑制剂,但与L-Tyr–D-Phe连接的双链肽的活性高于与L-Tyr–L-Phe连接的那种。此外,我们显示了处理过双(y-Tyr–x-Phe)-N,N-十二烷-1,12-二胺后的酪氨酸磷酸化的SDS-PAGE凝胶谱与酪氨酸激酶抑制剂erbstatin的类似物处理后的磷酸化谱非常相似。此外,处理过双(L-Tyr–D-Phe)-N,N-十二烷-1,12-二胺的表皮生长因子受体激酶域(EGFRKD)的自磷酸平低于处理过双(L-Phe–D-Phe)-N,N-十二烷-1,12-二胺的情况。这些数据为通过药物设计控制癌细胞增殖提供了新视角,药物设计用更具活性的–L-Tyr–L-Phe–(及–L-Tyr–D-Phe–)序列替代活性较低的–L-Phe–L-Phe–(及–D-Phe–L-Phe–)序列。
  • SYNTHESIS OF DIAMIDO GELLANTS BY USING DANE SALTS OF AMINO ACIDS
    申请人:EVONIK INDUSTRIES AG
    公开号:US20150073172A1
    公开(公告)日:2015-03-12
    The invention relates to a method for the synthesis of a compound according to formula I comprising the following steps: a) reacting a Dane salt according to formula II and a Dane salt according to formula III with a coupling reagent; b) adding a diamine according to formula IV to the reaction mixture; and c) adding an acid to the reaction mixture to adjust the pH value of the reaction to <7; wherein L represents a C 2 -C 20 alkyl group, a C 6 -C 20 aryl group, or a C 7 -C 20 alkylaryl group; R 1 and R 2 can be identical or different and represent a hydrogen atom, a C 1 -C 4 alkyl group, a C 1 -C 4 hydroxyalkyl group, a C 1 -C 4 thioether group, a C 6 -C 20 aryl group, a C 7 -C 26 ) alkylaryl group, a C 7 -C 20 alkylhydroxyaryl group, a C 4 -C 20 alkylheteroaryl group with 1 to 4 heteroatoms; or a C 1 -C 4 alkylcarboxylic moiety, which may be an acid, an amide, or which may be esterified with a C 1 -C 6 alkyl group or a C 7 -C 20 alkylaryl group; R 3 represents a C 1 -C 4 alkyl group; R 4 represents a hydrogen atom, or a C 1 -C 4 alkyl group; R 5 represents a C 1 -C 4 alkyl group; and X represents an alkali metal.
    本发明涉及一种合成配方I化合物的方法,包括以下步骤:a)用偶联试剂反应式II和式III的Dane盐;b)向反应混合物中加入式IV的二胺;c)向反应混合物中加入酸,以调节反应的pH值小于7;其中L代表C2-C20烷基、C6-C20芳基或C7-C20烷基芳基;R1和R2可以相同也可以不同,代表氢原子、C1-C4烷基、C1-C4羟基烷基、C1-C4醚基、C6-C20芳基、C7-C26烷基芳基、C7-C20烷基羟基芳基、具有1至4个杂原子的C4-C20烷基杂芳基或C1-C4烷基羧酸基,可以是酸、酰胺或酯化为C1-C6烷基或C7-C20烷基芳基;R3代表C1-C4烷基;R4代表氢原子或C1-C4烷基;R5代表C1-C4烷基;X代表碱属。
  • SYNTHESIS OF DIAMIDO GELLANTS BY USING AMINO ACID N-CARBOXYANHYDRIDES
    申请人:Bindl Martin
    公开号:US20150175527A1
    公开(公告)日:2015-06-25
    The invention relates to a method for the synthesis of a compound according to formula I comprising the following steps: a) reacting a N-carboxyanhydride according to formula II and a N-carboxy-anhydride according to formula III with a diamine according to formula IV and b) adding an acid to the reaction to adjust the pH value of the reaction to <7; wherein L represents a C 2 -C 20 alkyl group, a C 6 -C 20 aryl group, or a C 7 -C 20 alkylaryl group; and R 1 and R 2 can be identical or different and represent a hydrogen atom, a C 1 -C 4 alkyl group, a C 1 -C 4 hydroxyalkyl group, a C 1 -C 4 thioether group, a C 6 -C 20 aryl group, a C 7 -C 20 alkylaryl group, a C 7 -C 20 alkylhydroxyaryl group, a C 4 -C 20 alkylheteroaryl group with 1 to 4 heteroatoms; or a C 1 -C 4 alkylcarboxylic moiety, which may be an acid, an amide, or which may be esterified with a C 1 -C 6 alkyl group or a C 7 -C 20 alkylaryl group.
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸